Bifendate is a newly developed drug by Professor Xie Jingxi and others from the IMM, CAMS, based on the hepatoprotective active ingredients of the traditional Chinese medicine Schisandra chinensis. It has won the Class A Award for Scientific and Technological Achievements of the Ministry of Health of the PRC in 1981, the Third Prize for National Invention in 1983, and the Gold Award at the 1986 Brussels Eureka World Invention Expo.

Bifendate is an insoluble drug. Researchers of the IMM have developed a 1.5 mg dropping pill with high bioavailability using solid dispersion technology. In 1983, the Beijing Municipal Health Bureau approved our company’s predecessor, Experimental Pharmaceutical Factory, to produce Bifendate dropping pills. This drug was recognized as a Beijing Independent Innovation Product in 2009 and was selected as one of the top ten scientific and technological achievements of the 60th anniversary of the establishment of CAMS in 2016.

Bifendate have been included in Reimbursement Scope of Public Medical Medications in 1995, Pharmacopoeia of the People’s Republic of China since the 1995 edition, National Essential Medicines Catalog since the 1996 edition, and National Basic Medical Insurance Drug Catalog since the 2000 edition over the years. It is the only Class A variety for “liver treatment drugs and anti-fatty liver drugs” and have played an active role in the adjuvant treatment of liver diseases in community clinical practice in China.